The influence of intracellular epidermal growth factor receptor (EGFR) signal activation on the outcome of EGFR tyrosine kinase inhibitor treatment for pulmonary adenocarcinoma

Surgery Today ◽

10.1007/s00595-011-4514-2 ◽

2011 ◽

Vol 41 (6) ◽

pp. 818-823 ◽

Author(s):

Daigo Kawano ◽

Tokujiro Yano ◽

Fumihiro Shoji ◽

Kensaku Ito ◽

Yosuke Morodomi ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Egfr Tyrosine Kinase Inhibitor ◽

Epidermal Growth ◽

Signal Activation ◽

Inhibitor Treatment

Download Full-text

Quantification of epidermal growth factor receptor ( EGFR ) mutation may be a predictor of EGFR ‐tyrosine kinase inhibitor treatment response

Thoracic Cancer ◽

10.1111/1759-7714.12378 ◽

2016 ◽

Vol 7 (6) ◽

pp. 639-647 ◽

Author(s):

Ha Young Park ◽

Hyung Joo Oh ◽

Ki‐Hyun Kim ◽

Tae‐Ok Kim ◽

Cheol‐Kyu Park ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase Inhibitor ◽

Egfr Mutation ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Egfr Tyrosine Kinase Inhibitor ◽

Epidermal Growth ◽

Inhibitor Treatment

Download Full-text

Cytoplasmic YAP Expression is Associated with Prolonged Survival in Patients with Lung Adenocarcinomas and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment

Annals of Surgical Oncology ◽

10.1245/s10434-014-3715-5 ◽

2014 ◽

Vol 21 (S4) ◽

pp. 610-618 ◽

Author(s):

Ping-Li Sun ◽

Ji Eun Kim ◽

Seol Bong Yoo ◽

Hyojin Kim ◽

Yan Jin ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Lung Adenocarcinomas ◽

Inhibitor Treatment

Download Full-text

Abstract CT032: TATTON Phase Ib expansion cohort: Osimertinib plus savolitinib for patients (pts) withEGFR-mutant,MET-amplified NSCLC after progression on prior first/second-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)

10.1158/1538-7445.am2019-ct032 ◽

2019 ◽

Author(s):

Helena Yu ◽

Myung-Ju Ahn ◽

Sang-We Kim ◽

Byoung Chul Cho ◽

Lecia Sequist ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Egfr Tyrosine Kinase Inhibitor ◽

Phase Ib ◽

Epidermal Growth ◽

Expansion Cohort

Download Full-text

Abstract CT032: TATTON Phase Ib expansion cohort: Osimertinib plus savolitinib for patients (pts) withEGFR-mutant,MET-amplified NSCLC after progression on prior first/second-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)

10.1158/1538-7445.sabcs18-ct032 ◽

2019 ◽

Author(s):

Helena Yu ◽

Myung-Ju Ahn ◽

Sang-We Kim ◽

Byoung Chul Cho ◽

Lecia Sequist ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Egfr Tyrosine Kinase Inhibitor ◽

Phase Ib ◽

Epidermal Growth ◽

Expansion Cohort

Download Full-text

Schedule-dependent effects of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib in combination with the mammalian target of rapamycin (mTOR) inhibitor everolimus (RAD001)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.3074 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3074-3074 ◽

Author(s):

S. Di Cosimo ◽

P. Matar ◽

F. Rojo ◽

M. Guzman ◽

S. Rodriguez ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase Inhibitor ◽

Mtor Inhibitor ◽

Kinase Inhibitor ◽

Mammalian Target Of Rapamycin ◽

Growth Factor Receptor ◽

Egfr Tyrosine Kinase Inhibitor ◽

Epidermal Growth

Download Full-text

In silico study of 1-benzoyl-3-methylthiourea derivatives activity as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor candidates

Chemical Data Collections ◽

10.1016/j.cdc.2021.100741 ◽

2021 ◽

pp. 100741

Author(s):

Ruswanto Ruswanto ◽

Amir M. Miftah ◽

Daryono H. Tjahjono ◽

Siswandono

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase Inhibitor ◽

In Silico ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Egfr Tyrosine Kinase Inhibitor ◽

In Silico Study ◽

Epidermal Growth

Download Full-text

The Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor AG1478 Increases the Formation of Inactive Untethered EGFR Dimers

Journal of Biological Chemistry ◽

10.1074/jbc.m605136200 ◽

2006 ◽

Vol 282 (5) ◽

pp. 2840-2850 ◽

Author(s):

Hui K. Gan ◽

Francesca Walker ◽

Antony W. Burgess ◽

Angela Rigopoulos ◽

Andrew M. Scott ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Tyrosine Kinase ◽

Epidermal Growth

Download Full-text

Schedule-dependent effects of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib in combination with the mammalian target of rapamycin (mTOR) inhibitor everolimus (RAD001)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.3074 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3074-3074

Author(s):

S. Di Cosimo ◽

P. Matar ◽

F. Rojo ◽

M. Guzman ◽

S. Rodriguez ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase Inhibitor ◽

Mtor Inhibitor ◽

Kinase Inhibitor ◽

Mammalian Target Of Rapamycin ◽

Growth Factor Receptor ◽

Egfr Tyrosine Kinase Inhibitor ◽

Epidermal Growth

Download Full-text

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Lung Adenocarcinomas with G719X/L861Q/S768I Mutations

Journal of Thoracic Oncology ◽

10.1097/jto.0000000000000504 ◽

2015 ◽

Vol 10 (5) ◽

pp. 793-799 ◽

Author(s):

Chao-Hua Chiu ◽

Cheng-Ta Yang ◽

Jin-Yuan Shih ◽

Ming-Shyan Huang ◽

Wu-Chou Su ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Lung Adenocarcinomas ◽

Inhibitor Treatment

Download Full-text

Enhanced Efficacy of Radioimmunotherapy with 90Y-CHX-A″-DTPA-hu3S193 by Inhibition of Epidermal Growth Factor Receptor (EGFR) Signaling with EGFR Tyrosine Kinase Inhibitor AG1478

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-1004-0019 ◽

2005 ◽

Vol 11 (19) ◽

pp. 7080s-7086s ◽

Author(s):

Fook T. Lee ◽

Angela J. Mountain ◽

Marcus P. Kelly ◽

Cathrine Hall ◽

Angela Rigopoulos ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Egfr Signaling ◽

Egfr Tyrosine Kinase Inhibitor ◽

Epidermal Growth

Download Full-text